Department of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.
Clinical and Quality Analysis, Partners HealthCare, Somerville, Massachusetts, United States.
Appl Clin Inform. 2018 Apr;9(2):268-274. doi: 10.1055/s-0038-1642608. Epub 2018 Apr 25.
This article aims to understand provider behavior around the use of the override reason "Inaccurate warning," specifically whether it is an effective way of identifying unhelpful medication alerts.
We analyzed alert overrides that occurred in the intensive care units (ICUs) of a major academic medical center between June and November 2016, focused on the following high-significance alert types: dose, drug-allergy alerts, and drug-drug interactions (DDI). Override appropriateness was analyzed by two independent reviewers using predetermined criteria.
A total of 268 of 26,501 ICU overrides (1.0%) used the reason "Inaccurate warning," with 93 of these overrides associated with our included alert types. Sixty-one of these overrides (66%) were identified to be appropriate. Twenty-one of 30 (70%) dose alert overrides were appropriate. Forty of 48 drug-allergy alert overrides (83%) were appropriate, for reasons ranging from prior tolerance ( = 30) to inaccurate ingredient matches ( = 5). None of the 15 DDI overrides were appropriate.
The "Inaccurate warning" reason was selectively used by a small proportion of providers and overrides using this reason identified important opportunities to reduce excess alerts. Potential opportunities include improved evaluation of dosing mechanisms based on patient characteristics, inclusion of institutional dosing protocols to alert logic, and evaluation of a patient's prior tolerance to a medication that they have a documented allergy for. This resource is not yet routinely used for alert tailoring at our institution but may prove to be a valuable resource to evaluate available alerts.
本文旨在了解围绕使用“警告不准确”这一 override 原因的医疗服务提供者的行为,尤其是该原因是否是识别无益药物警报的有效方法。
我们分析了 2016 年 6 月至 11 月期间一家主要学术医疗中心的重症监护病房(ICU)中发生的警报 override,重点关注以下高显著性警报类型:剂量、药物过敏警报和药物相互作用(DDI)。使用预定标准,由两名独立评审员分析 override 的适当性。
在总共 26,501 次 ICU override 中,有 268 次(1.0%)使用了“警告不准确”这一原因,其中 93 次与我们包括的警报类型相关。这些 override 中有 61 次(66%)被认为是适当的。21 次(70%)剂量警报 override 是适当的,原因包括先前的耐受( = 30)和不准确的成分匹配( = 5)。48 次药物过敏警报 override 中有 40 次(83%)是适当的,原因包括先前的耐受( = 30)和不准确的成分匹配( = 5)。15 次药物相互作用 override 均不适当。
“警告不准确”这一原因是由一小部分医疗服务提供者选择性使用的,使用这一原因的 override 确定了减少过量警报的重要机会。潜在的机会包括根据患者特征改进剂量机制评估、将机构剂量方案纳入警报逻辑以及评估患者对他们有记录的过敏药物的先前耐受性。该资源在我们机构尚未常规用于警报定制,但可能被证明是评估可用警报的有价值的资源。